Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Mitochondrial dysfunction and oxidative stress are implicated in the neurodegenerative process in Parkinson's disease (PD). Moreover, c-Jun N-terminal kinase (JNK) plays an important role in dopaminergic neuronal death in substantia nigra pars compacta. Tauroursodeoxycholic acid (TUDCA) acts as a mitochondrial stabilizer and anti-apoptotic agent in several models of neurodegenerative diseases. Here, we investigated the role of TUDCA in preventing 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurodegeneration in a mouse model of PD. We evaluated whether TUDCA modulates MPTP-induced degeneration of dopaminergic neurons in the nigrostriatal axis, and if that can be explained by regulation of JNK phosphorylation, reactive oxygen species (ROS) production, glutathione S-transferase (GST) catalytic activation, and Akt signaling, using C57BL/6 glutathione S-transferase pi (GSTP) null mice. TUDCA efficiently protected against MPTP-induced dopaminergic degeneration. We have previously demonstrated that exacerbated JNK activation in GSTP null mice resulted in increased susceptibility to MPTP neurotoxicity. Interestingly, pre-treatment with TUDCA prevented MPTP-induced JNK phosphorylation in mouse midbrain and striatum. Moreover, the anti-oxidative role of TUDCA was demonstrated in vivo by impairment of ROS production in the presence of MPTP. Finally, results herein suggest that the survival pathway activated by TUDCA involves Akt signaling, including downstream Bad phosph…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tauroursodeoxycholic acid (TUDCA), an endogenous bile acid, has a neuroprotective effect in models of Parkinson's disease.[214][215][216]”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [214]
In the citing paper
“Multiple in vivo studies have demonstrated the neuroprotective effects of UDCA and TUDCA in counteracting mitochondrial dysfunction, oxidative stress, and neuroinflammation within PD mouse models.386–392”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [388]
Citations
Cites
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 2×
“This kinase may be activated by phosphorylation within the carboxy terminus at Ser 473 [40].”
BackgroundMethodAkt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689 · cited 1×
“Active Akt directly phosphorylates Bad on Ser 136, triggering the release of Bad from its mitochondrial targets [53].”
BackgroundDauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · cited 2×
“The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin constitutes the best-characterized toxin paradigm for PD, faithfully replicating most of its clinical and pathological hallmarks in humans and animal models [1].”
BackgroundInterleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
Peso, L. D., González-Garcı́a, M., Page, C., Herrera, R., & Nuñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 1,797 · cited 1×
“Pro-apoptotic Bad forms heterodimers with the anti-apoptotic proteins Bcl-xL or Bcl-2, antagonizing their anti-apoptotic activity [52].”
BackgroundMolecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663 · cited 1×
“Several possible mechanisms leading to dopaminergic neurodegeneration in PD have been proposed, including mitochondrial complex I dysfunction, impairment of ATP production, oxidative stress, neuroinflammation, and aberrant proteolytic degradation [3].”
BackgroundNF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Regulation of JNK signaling by GSTp
Adler, V. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1321 · Cited by 1,116 · cited 1×
“In GSTP null mice, the constitutive activation of JNK pathway is higher [47, 48].”
BackgroundSelf-citationInduction of NF-κB by the Akt/PKB kinase
Kane, L. P., Shapiro, V. S., Stokoe, D., & Weiss, A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80265-6 · Cited by 846
Rodrigues, C. M., Fan, G., Ma, X., Kren, B. T., & Steer, C. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1325 · Cited by 520 · cited 1×
“drial membrane potential, and prevent cytochrome c release, Bax translocation, caspase activation, and apoptosis in hepatocytes exposed to apoptotic stimuli [18, 22, 23].”
BackgroundSelf-citationMorrish, P. K., Rakshi, J. S., Bailey, D. L., Sawle, G. V., & Brooks, D. J. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.314 · Cited by 510 · cited 1×
“In PD, approximately 50–70% of the dopaminergic neurons are already lost at the time of clinical diagnosis [55].”
Background
Cited by
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
Paganoni, S., Macklin, E. A., Hendrix, S., Berry, J. D., Elliott, M. A., Maiser, S., Karam, C., Caress, J. B., Owegi, M. A., Quick, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916945 · Cited by 536
Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A., & Covasa, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020436 · Cited by 307
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
The therapeutic potential of chemical chaperones in protein folding diseases
Cortez, L., & Sim, V. (2014) · Prion · doi:10.4161/pri.28938 · Cited by 254
“Additionally, intraperitoneal injection of TUDCA in mouse model of PD prevented dopaminergic cell death through the activation of pro-survival pathways.(59) Future therapeutic potential Bile acids, in particular TUDCA and UDCA, have received increasing attention as potential treatments for neurodegenerative conditions…”
Background
Metadata
- Authors
- Castro-Caldas, M., Carvalho, A. N., Rodrigues, E., Henderson, C. J., Wolf, C. R., Rodrigues, C. M. P., & Gama, M. J.
- Affiliations
- University of Lisbon (PT)
- Ninewells Hospital (GB)
- Corresponding author
- Gama, M. J.
- Venue
- Molecular Neurobiology
- Published
- 2012-07-08
- Volume
- 46
- Issue
- 2
- Pages
- 475-486
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2034424279
- Cited by
- 156
- References
- 56
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 10 · 2023: 19 · 2022: 15 · 2021: 13 · 2020: 13 · 2019: 13 · 2018: 10 · 2017: 10 · 2016: 12 · 2015: 6 · 2014: 9 · 2013: 5
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Cancer Research UK (10822)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Keywords
- tauroursodeoxycholic acid, Parkinson's disease, MPTP-induced neurotoxicity, dopaminergic neuron loss, substantia nigra pars compacta, c-Jun N-terminal kinase, JNK phosphorylation, oxidative stress, reactive oxygen species, glutathione S-transferase pi, Akt signaling, Bad phosphorylation, NF-κB, neuroprotection, mitochondrial dysfunction, nigrostriatal pathway
- MeSH terms
- NF-KappaB Inhibitor alpha, Animals, Disease Models, Animal, Mice, Inbred C57BL, Nerve Degeneration, Parkinson Disease, Phosphorylation, Taurochenodeoxycholic Acid, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, NF-kappa B, Cell Death, Reactive Oxygen Species, Mice, Knockout, Neuroprotective Agents, I-kappa B Proteins, Intracellular Space, JNK Mitogen-Activated Protein Kinases, bcl-Associated Death Protein, Mice, HSP27 Heat-Shock Proteins, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease. https://app.cochat.ai/papers/10.1007/s12035-012-8295-4
- The paper
- Castro-Caldas, M., Carvalho, A. N., Rodrigues, E., Henderson, C. J., Wolf, C. R., Rodrigues, C. M. P., & Gama, M. J. (2012). Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease. Molecular Neurobiology. https://doi.org/10.1007/s12035-012-8295-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.